GENE ONLINE|News &
Opinion
Blog

Partner
CYTENA Bioprocess Solutions Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals
2021-10-05Partner
Taiwan’s AMS BioteQ Develops a New Antimicrobial Dressing Which Accelerates Diabetes Wound Healing
2021-09-22Partner
VIRTUALMAN Breaking Barriers in Drug Development with AI Solutions
2021-08-05Partner
A Boom in High-Value M&A and Licensing Deals in the Exosome Field
2021-08-02Partner
The Future of Precision Medicine: From Gene Therapy to Data Sharing Boom – Excerpts from the US-Taiwan Precision Medicine Forum
2021-07-21Partner
AI Technology Revamping Drug Development! VIRTUALMAN to Demonstrate Powerful Solutions in BIO Asia-Taiwan 2021
2021-07-15Partner
Is Heterologous Prime-Boost of COVID-19 Vaccines the Way to Go?
2021-05-30Partner
Is Exosome the Next Rising Star?
2021-05-23Partner
How Can Organoid and Mouse Models Boost Oncology Preclinical Trials? – Highlights from the Crown Biosciences Symposium
2021-03-10Partner
Asia Microbiome Conference Highlights: COVID-19 Variants, New Strain Culturing, and Upcoming Trends
2021-01-28Partner
Cytena Bioprocess Solutions Closes Pre-A series Funding, Accelerates Development in Microbioreactors
2020-12-29Partner
Taiwanese Startup, Micronbrane Aims to Improve Detection of Microbial Pathogens
2020-12-21Partner
Advance Precision Medicine by Applying Circulating Tumor Cells for Anti-Cancer Drug Screen
2020-10-20Partner
ITALY Pavilion Offers Immense Value at BIO ASIA-TAIWAN 2020 – ONLINE
2020-10-13Partner
HoldingTOP Delivers a Mobilized Long-Term Care Service, a First in Taiwan
2020-10-13Partner
1 2 3 4
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!